DNA SEQ 2, INC.
Pharmaceuticals · VISTA, CA
PharmaceuticalsSEC Form D
DNA SEQ 2, INC. filed a Form D with the U.S. Securities and Exchange Commission on March 11, 2026, reporting $1,176,300 raised.
Incorporated in Delaware and based in VISTA, CA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that DNA SEQ 2, INC. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Andrew NappinExecutive Officer
- Stuart E. SiegelDirector
- Janusz Maria SowadskiDirector
- Eric LadizinskyDirector
- Thomas M. WheelerDirector
- Benjamin AndersonDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised
CNS Pharmaceuticals, Inc.
$4.9MRaised